AIP
DNA icon

Ameritas Investment Partners’s Ginkgo Bioworks DNA Stock Holding History

Ameritas Investment Partners’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.8K Buy
4,322
+1,038
+32% +$8.68K ﹤0.01% 2342
2026
Q1 		$20.1K Hold
3,284
– – ﹤0.01% 2592
2025
Q4 		$27.3K Hold
3,284
– – ﹤0.01% 2493
2025
Q3 		$47.9K Sell
3,284
-685
-17% -$8.2K ﹤0.01% 2158
2025
Q2 		$44.7K Buy
+3,969
New +$30.7K ﹤0.01% 2258

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Ameritas Investment Partners's DNA Position: Q2 2026 in Review

Ameritas Investment Partners increased its Ginkgo Bioworks (DNA) stake by 32% in Q2 2026, buying an estimated $8.68K and bringing the position to 4,322 shares worth $42.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2342.

Ameritas Investment Partners first reported a position in DNA in Q2 2025 and has held it in 5 quarters since. The position peaked at $47.9K in Q3 2025. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Ameritas Investment Partners held 4,322 shares of Ginkgo Bioworks worth $42.8K as of Q2 2026.
  • Ameritas Investment Partners bought 1,038 Ginkgo Bioworks shares in Q2 2026, an estimated $8.68K.
  • Ginkgo Bioworks made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2342 holding.
  • Ameritas Investment Partners first reported a position in Ginkgo Bioworks in Q2 2025 and has held it in 5 quarters since.
  • Ameritas Investment Partners's Ginkgo Bioworks position peaked at $47.9K in Q3 2025.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.